Survivingbreastcancer.org4 minBlogPiqray (Alpelisib) for HR+ HER2- PIK3CA-Mutated, MBCBy Abigail Johnston Piqray (Alpelisib) was the first new drug application (NDA) for a new molecular entity approved under the Real-Time...